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anglais
INTRODUCTION: Pancreatectomies increase the risk of postoperative pancreatic
fistula (POPF) and pancreatic insufficiency. Pancreatic enucleation preserves
pancreatic parenchyma, lowers the risk of pancreatic insufficiency, but may induce
specific complications (tumor recurrence or pancreatic fistulization). The aim of
this study was to determine the risk factors for POPF following a pancreatic
enucleation.
METHODS: A retrospective analysis was designed based on data from patients
who underwent pancreatic enucleation in five university hospitals (1998-2008). The
presence of a pancreatic fistula was determined according to the criteria of the
International Study Group of Pancreatic Fistula (Bassi et al. Surgery 138:8-13,
2005).
RESULTS: Fifty-two patients (mean age 52 years) were included. Histological
analysis revealed 35 endocrine tumors (68.6 %), 6 mucinous and 2 serous cyst
adenomas, 2 metastases of renal cancer, and 8 benign tumors. Nineteen patients
(36.5%) suffered postoperative complications including 14 POPF (27 %). Median
postoperative hospital stay was 12.9 days; 9.1 days without POPF versus 29 days
with POPF (p < 0.05). Size of the tumor, its location, histological differentiation,
and use of somatostatin analogs were not predictors for POPF. We defined the
cutoff for POPF at a distance of 2 mm from the main pancreatic duct based on 60%
risk (≤2 mm) versus 19 % (>2 mm) of POPF (p < 0.01). With a mean follow-up of
30.8 months, one patient experienced recurrence of the tumor. No patients
exhibited a new onset of diabetes or pancreatic insufficiency.
CONCLUSION: Enucleation for resection of pancreatic tumors located at less than
or equal to two 2 mm from the main pancreatic duct is a risk factor for POPF.
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